Federation des caisses Desjardins du Quebec’s TherapeuticsMD TXMD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4	Closed	-$974	–	2240
2018 Q1	$974	Hold	4	–	–	﹤0.01%	2060
2017 Q4	$1.21K	Hold	4	–	–	﹤0.01%	2042
2017 Q3	$1.06K	Sell	4 -304	-99%	-$87.9K	﹤0.01%	1994
2017 Q2	$81.2K	Sell	308 -559	-64%	-$140K	﹤0.01%	1269
2017 Q1	$312K	Buy	+867	New	+$268K	0.01%	817

Other funds holding TXMD

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TXMD Position: Q2 2018 in Review

Federation des caisses Desjardins du Quebec sold out of TherapeuticsMD (TXMD) in Q2 2018, closing a stake of 4 shares — an estimated $974 sold.

Federation des caisses Desjardins du Quebec first reported a position in TXMD in Q1 2017 and held it in 5 quarters. The position peaked at $312K in Q1 2017. 143 funds tracked by Wall St. Rank hold TXMD as of Q2 2018.

Federation des caisses Desjardins du Quebec reported no remaining TherapeuticsMD position as of Q2 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 4 TherapeuticsMD shares in Q2 2018, an estimated $974.
Federation des caisses Desjardins du Quebec first reported a position in TherapeuticsMD in Q1 2017 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's TherapeuticsMD position peaked at $312K in Q1 2017.
143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2018, filed 30 Aug 2024.